SUPRAME Trademark

Trademark Overview

On Wednesday, March 26, 2025, a trademark application was filed for SUPRAME with the United States Patent and Trademark Office. The USPTO has given the SUPRAME trademark a serial number of 99104160. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, September 26, 2025. This trademark is owned by Immatics Biotechnologies GmbH. The SUPRAME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting of medical, scientific and clinical research in the field of engineered T-cell receptor-based immunotherapy against solid cancer; medical and scientific research in the nature of conducting clinical trials for others in the field of engineered T-cell receptor-based immunotherapy against solid cancer, and providing corresponding medical and scientific research information
suprame

General Information

Serial Number99104160
Word MarkSUPRAME
Filing DateWednesday, March 26, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, September 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesConducting of medical, scientific and clinical research in the field of engineered T-cell receptor-based immunotherapy against solid cancer; medical and scientific research in the nature of conducting clinical trials for others in the field of engineered T-cell receptor-based immunotherapy against solid cancer, and providing corresponding medical and scientific research information

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 26, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmatics Biotechnologies GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTübingen 72076
DE

Trademark Events

Event DateEvent Description
Thursday, July 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 11, 2025NON-FINAL ACTION WRITTEN
Friday, September 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 26, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 11, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 26, 2025NEW APPLICATION ENTERED
Wednesday, March 26, 2025APPLICATION FILING RECEIPT MAILED
Monday, August 25, 2025ASSIGNED TO EXAMINER
Thursday, September 11, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

suprame research scientific medical immunotherapy against cancer conducting solid based receptor